Previous 10 | Next 10 |
2024-04-09 10:03:48 ET More on Madrigal Pharmaceuticals Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly I...
2024-04-09 10:00:00 ET CRISPR Therapeutics (NASDAQ: CRSP) and Viking Therapeutics (NASDAQ: VKTX) are among the hottest mid-cap biotechs on the market. Both have delivered incredible progress in recent months, be it on the clinical or regulatory front. These relatively small ...
2024-04-08 05:55:00 ET Viking Therapeutics (NASDAQ: VKTX) has shown its strengths from a potential product perspective and an investment perspective in recent times. The company reported excellent data from clinical trials of two formulations of its leading weight loss drug candidat...
2024-04-06 07:45:00 ET One of the hottest areas of the pharmaceutical industry right now is the weight loss treatment space. Novo Nordisk and Eli Lilly have been the primary innovators. Their groundbreaking glucagon-like peptide-1 (GLP-1) agonists are in high demand for both diabete...
2024-04-05 07:15:00 ET Madrigal Pharmaceuticals (NASDAQ: MDGL) and Viking Therapeutics (NASDAQ: VKTX) are both biotechs developing treatments for metabolic diseases, so it's to be expected that they have more than a few things in common. But investors are probably interested...
2024-04-04 09:15:00 ET Are we witnessing the rise of a new biotech giant? A few weeks ago, Viking Therapeutics (NASDAQ: VKTX) grabbed headlines when it reported positive results from a phase 2 clinical trial for VK2735, a potential anti-obesity medicine. That was quite an accomplish...
2024-04-04 06:30:00 ET Viking Therapeutics (NASDAQ: VKTX) is on a tear this year, with shares catapulting upward by 340% thanks to good data (and high expectations) from one of its mid-stage clinical trials testing a weight loss drug. The data readouts from that program alone were e...
2024-04-04 05:50:00 ET What's the most important ingredient for investing successfully? Time. However, some stocks require much less time to deliver huge returns than others. You may have to be patient for significant returns if you invest in stocks that are about to announce major news...
2024-04-04 04:55:00 ET Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have seen their revenue soar in recent times thanks to their weight loss drugs. The companies sell products that target key hormones involved in the regulation of blood sugar levels and appetite, and t...
2024-04-02 12:13:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reduced interest rates make it easier for firms to buy other companies. That’s because acquiring firms can borrow the money needed to finance mergers and acquisitions (M&A) deals...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 44.59% on an annualized basis producing an average annual re...
2024-04-28 10:30:00 ET Viking Therapeutics (NASDAQ: VKTX) has emerged as a beacon of hope in an otherwise lackluster year for healthcare stocks. The buzz around its mid-stage weight loss candidate, VK2735, has propelled the biotech's stock to a staggering 714% surge since the comple...
2024-04-28 09:07:00 ET Viking Therapeutics (NASDAQ: VKTX) has been flying on all cylinders since the beginning of the year. The company's shares are up 246% due to excellent clinical progress. It's not rare for smaller biotechs to see their stock prices skyrocket relatively quickly,...